SCHEMBL15575262

SCHEMBL15575262

O=C1/C=C\Cc2ccccc2[N+](=O)N1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11880028 0.77 HTR6 (0.31)
SCHEMBL6136738 0.67 AHR (0.48) CA1CA2
SCHEMBL2461757 0.66 HTR6 (0.33)
Hydrochloric Acid SCHEMBL7370281 0.64 HTR6 (0.33)
SCHEMBL530203 0.63 HTR6 (0.33)
SCHEMBL10477406 0.63 KDM4E (0.33) CA1CA2
SCHEMBL11611587 0.63 CYP1A2 (0.33)
Indene SCHEMBL28982398 0.62 CA1 (0.43) CA1CA2
SCHEMBL4716685 0.61 HTR2C (0.43)
SCHEMBL7803968 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2890986-B1 METHOD OF SELECTING INDIVIDUALIZED BRAIN CANCER THERAPY TURUN YLIOPISTO (FI) 2017-06-21 EP disclosed
EP-2890986-A1 METHOD OF SELECTING INDIVIDUALIZED BRAIN CANCER THERAPY Turun Yliopisto (FI) 2015-07-08 EP disclosed
WO-2014033367-A1 METHOD OF SELECTING INDIVIDUALIZED BRAIN CANCER THERAPY TURUN YLIOPISTO (FI) 2014-03-06 WO disclosed